Director, Quality Systems

San Diego · On-site$170k – $210k

About this role

Description

The Director Quality Systems will lead and support quality assurance and quality systems activities for Viking’s clinical and commercial-stage operations. The role advances the company's Quality Management System, drives inspection readiness, and ensures quality processes are scalable, compliant, and aligned with late-stage development and commercial launch. The ideal candidate brings hands-on QA and Quality Systems experience, deep knowledge of GMP and FDA requirements, and a proven ability to partner cross-functionally to build a proactive, risk-based quality culture.

Essential Duties and Responsibilities

The main responsibilities of this role include: 

  • Lead and manage the QS team, ensuring alignment with company objectives and regulatory standards 
  • Develop, implement, and maintain quality management strategies and systems to ensure compliance with GMP, FDA, ICH guidelines, and other relevant regulatory bodies 
  • Design, establish, and continuously improve the Quality Management System (QMS), including document control, change control, training systems, and electronic quality systems (eQMS) within Veeva.
  • Oversee the entire quality systems infrastructure, including Standard Operating Procedures (SOPs), Policies, batch records, specifications, testing, validation protocols and other GMP CMC documents.
  • Manage document lifecycle management ensuring version control, approval workflows, and archival in compliance with regulatory requirements 
  • Establish and maintain quality metrics dashboards and Key Performance Indicators (KPIs) for system effectiveness 
  • Establish and enforce quality assurance policies and procedures across all operational departments 
  • Support the preparation and execution of internal audits, including regulatory inspections, to ensure compliance with regulatory requirements 
  • Ensure timely resolution of quality-related issues, including non-conformances, deviations, and CAPA (Corrective and Preventive Actions) 
  • Maintain inspection readiness and serve as primary QA point of contact for regulatory inspections 
  • Collaborate with cross-functional teams (R&D, manufacturing, regulatory affairs, supply chain, etc.) to ensure product quality throughout the entire lifecycle 
  • Partner with Regulatory Affairs to support CMC sections of regulatory submissions (IND, BLA, NDA) 
  • Support technology transfer activities and new product introductions from a quality systems perspective 
  • Lead continuous improvement initiatives leveraging methodologies to enhance product quality, manufacturing processes, and operational efficiency 
  • Provide leadership in Quality Risk Management (QRM), including identification, assessment, and mitigation of quality risks using ICH Q9 principles 
  • Prepare and present quality performance metrics, trending analysis, and reports to senior management and board of directors 
  • Mentor and develop QS staff, fostering a culture of accountability, compliance, and continuous professional growth 
  • Other duties as assigned.

Requirements

Education and Experience

  • Bachelor's degree in Life Sciences, Engineering, or a related field 
  • 10+ years of progressive experience in Quality Assurance with at least 5 years in a leadership role within a regulated industry (pharmaceutical, biotechnology, or medical devices) 

Knowledge and Skills

  • Strong knowledge of regulatory requirements, including FDA, GMP, ICH guidelines, ISO 13485, and 21 CFR Parts 210, 211, 600, 820, and 1271 
  • Demonstrated expertise in Quality Management Systems (QMS) design, implementation, and maintenance 
  • Proven experience with electronic quality systems (eQMS) platforms such as Veeva
  • Knowledge of Quality Risk Management methodologies (ICH Q9, FMEA, etc.) 
  • Demonstrated ability to drive process improvements and manage complex quality systems in dynamic environments 
  • Experience managing regulatory inspections and audit readiness programs 
  • Excellent problem-solving, analytical, and decision-making skills 
  • Strong written and verbal communication skills, with the ability to interact with senior leadership, regulatory agencies, and external stakeholders 
  • Experience in preparing and presenting reports and metrics to senior management and board members 
  • Strong leadership and interpersonal skills, with the ability to mentor and guide teams towards excellence 
  • Ability to work effectively in a fast-paced, entrepreneurial environment with changing priorities  

VIKING THERAPEUTICS

Viking Therapeutics, Inc., is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Viking Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.

Notice to Agency and Search Firm Representatives

Viking Therapeutics, Inc. is not accepting unsolicited resumes from agencies and/or search firms for this job posting. Resumes submitted to any Viking employee by a third-party agency and/or search firm without a valid written & signed search agreement, and assignment of specific position, will become the sole property of Viking Therapeutics, Inc. No fee will be paid if a candidate is hired for this position as a result of an unsolicited agency or search firm referral.

Salary Description

$170,000.00 - $210,000.00 annual salary

#li-dni

Company at a glance

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).

Founded2012
Team Size51-200 employees
WorkspaceOn-site
IndustryPharmaceutical Manufacturing
Location
San Diego, California, United States

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

Know someone who'd be great for this?